The following articles (labelled with PubMed ID or TBD) are for your review
||Discovery of 2-[1-(4,4-Difluorocyclohexyl)piperidin-4-yl]-6-fluoro-3-oxo-2,3-dihydro-1H-isoindole-4-carboxamide (NMS-P118): A Potent, Orally Available, and Highly Selective PARP-1 Inhibitor for Cancer Therapy.
||Nerviano Medical Sciences Srl
||Discovery and optimization of pyrrolo[1,2-a]pyrazinones leads to novel and selective inhibitors of PIM kinases.
||Nerviano Medical Sciences
||Synthesis and structure-activity relationship of trisubstituted thiazoles as Cdc7 kinase inhibitors.
||The optimization of aminooxadiazoles as orally active inhibitors of Cdc7.
||Aminopyrimidinone cdc7 kinase inhibitors.
||NMS-P937, a 4,5-dihydro-1H-pyrazolo[4,3-h]quinazoline derivative as potent and selective Polo-like kinase 1 inhibitor.
||Nerviano Medical Sciences srl